Issued 2026-09-16 at $13.43 · now $13.43 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, RMIX has typically landed between $10.58 and $20.43 — a range of −21.2% to +52.1% from the issuance price $13.43.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
97 overlapping 1 month windows · 2026-03-30 – 2026-08-17 · basis climatology · forecast (batch).
The cone is anchored at the 2026-09-16 issuance close ($13.43) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where RMIX has typically landed a month from the 2026-09-16 close of $13.43 — the range is history, not a prediction.
- now $13.43 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $14 (+4.2%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $11.58–$16.41
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $10.58–$20.43
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2026-08-12 | −30.1% | −30.1% | +0.0% |
| 2026-08-13 | −29.4% | −29.4% | +0.0% |
| 2026-08-14 | −28.5% | −28.5% | +0.0% |
| 3 best | |||
| 2026-05-19 | +53.8% | −0.6% | +53.8% |
| 2026-04-02 | +52.7% | −5.2% | +52.7% |
| 2026-04-09 | +52.0% | +0.0% | +55.2% |
97 overlapping windows · 2026-03-30 – 2026-09-16 · not cherry-picked
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Harraden Circle Investments, LLC | tenPercentOwner | Sale | 503,426 @ $12.50 | $6.3M | −10.3% of holding | +31.7% | not yet — horizon still open | 4,384,563 | Form 4 · filed same day |
| 2026-04-15 | Harraden Circle Investments, LLC | tenPercentOwner | Sale | 5,895 @ $13.12 | $77K | −0.1% of holding | +26.9% | not yet — horizon still open | 4,899,716 | Form 4 · filed 1 day after the trade |
| 2026-04-14 | Harraden Circle Investments, LLC | tenPercentOwner | Sale | 17,622 @ $12.95 | $228K | −0.4% of holding | +28.2% | not yet — horizon still open | 4,887,989 | Form 4 · filed 2 days after the trade |
| 2026-04-13 | Harraden Circle Investments, LLC | tenPercentOwner | Sale | 17,184 @ $12.98 | $223K | −0.3% of holding | +18.8% | not yet — horizon still open | 4,905,611 | Form 4 · filed 2 days after the trade |
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
8 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-04-20 | Matteson Mark R | director | Award / grant | 96,000 | 96,000 | Form 4 |
| 2026-04-20 | Johnston Bretton A. | director | Award / grant | 48,000 | 48,000 | Form 4 |
| 2026-04-20 | Holden William C. | director | Award / grant | 48,000 | 272,631 | Form 4 |
| 2026-04-20 | Skelly Noreen E | director | Award / grant | 48,000 | 48,000 | Form 4 |
| 2026-04-20 | Owens Charles E | director | Award / grant | 48,000 | 48,000 | Form 4 |
| 2026-04-20 | Rees-Jones David | director | Award / grant | 48,000 | 48,000 | Form 4 |
| 2026-04-20 | HEYER ANDREW R | director | Award / grant | 48,000 | 48,000 | Form 4 |
| 2026-04-20 | Fleming Ned N III | director | Award / grant | 144,000 | 144,000 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.